Steward Partners Investment Advisory’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Steward Partners Investment Advisory’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-500	Closed	-$7.77K	–	7496
2021 Q1	$7.77K	Buy	+500	New	+$8.15K	﹤0.01%	2881
2019 Q4	–	Sell	-429	Closed	-$2K	–	2790
2019 Q3	$2K	Buy	429 +9	+2%	+$60	﹤0.01%	2472
2019 Q2	$3K	Buy	+420	New	+$6.4K	﹤0.01%	2394
2018 Q4	–	Sell	-220	Closed	-$8K	–	2318
2018 Q3	$8K	Hold	220	–	–	﹤0.01%	1989
2018 Q2	$8K	Hold	220	–	–	﹤0.01%	1840
2018 Q1	$10K	Buy	+220	New	+$8.05K	﹤0.01%	1583

Other funds holding KDNY

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steward Partners Investment Advisory's KDNY Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2021, closing a stake of 500 shares — an estimated $7.77K sold.

Steward Partners Investment Advisory first reported a position in KDNY in Q1 2018 and held it in 6 quarters. The position peaked at $10K in Q1 2018. 89 funds tracked by Wall St. Rank hold KDNY as of Q2 2021.

Steward Partners Investment Advisory reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Steward Partners Investment Advisory sold 500 Chinook Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $7.77K.
Steward Partners Investment Advisory first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2018 and held it in 6 quarters.
Steward Partners Investment Advisory's Chinook Therapeutics, Inc. Common Stock position peaked at $10K in Q1 2018.
89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.